DLReady Certification Awarded for Synergy 2 and Synergy HT Multi-Detection Microplate Readers
News Nov 06, 2006
BioTek Instruments has received DLReady™ certification for dual-luciferase assays on both the Synergy™ 2 and Synergy™ HT multi-detection microplate readers.
Awarded by Promega Corporation, this certification validates an instrument to the highest performance levels and standards for the Dual-Luciferase® Reporter (DLR™) Assay System, which is one of the most common luminescence-based assays for measuring gene transcription and control in microplate format.
The DLR Assay System provides rapid quantitation of firefly and Renilla luciferase reporters in transfected cells or in cell-free transcription/translation reactions. The combination of two reporter assays in one system provides improved efficiency in less time with attomole sensitivities and no endogenous activity in the experimental host cells.
Synergy 2 and Synergy HT multi-detection microplate readers provide flexibility and performance through a variety of detection modes in addition to luminescence and injection options, including Fluorescence Intensity, Time Resolved Fluorescence and UV-Vis Absorbance. Synergy 2 also offers Fluorescence Polarization and increased detection sensitivity. Each multi-detection microplate reader is powered by BioTek’s Gen5™ data analysis software.
BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. The BioTek Instruments, Inc. instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018